GB9917977D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9917977D0
GB9917977D0 GBGB9917977.2A GB9917977A GB9917977D0 GB 9917977 D0 GB9917977 D0 GB 9917977D0 GB 9917977 A GB9917977 A GB 9917977A GB 9917977 D0 GB9917977 D0 GB 9917977D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917977.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9917977(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9917977.2A priority Critical patent/GB9917977D0/en
Publication of GB9917977D0 publication Critical patent/GB9917977D0/en
Priority to AU68322/00A priority patent/AU6832200A/en
Priority to CA002380295A priority patent/CA2380295A1/en
Priority to JP2001513985A priority patent/JP2003506027A/ja
Priority to EP00956338A priority patent/EP1204678A1/en
Priority to PCT/EP2000/007293 priority patent/WO2001009179A1/en
Priority to CN00811120A priority patent/CN1367790A/zh
Priority to HK02107831.6A priority patent/HK1047943A1/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB9917977.2A 1999-07-30 1999-07-30 Novel compounds Ceased GB9917977D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9917977.2A GB9917977D0 (en) 1999-07-30 1999-07-30 Novel compounds
AU68322/00A AU6832200A (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof
CA002380295A CA2380295A1 (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof
JP2001513985A JP2003506027A (ja) 1999-07-30 2000-07-27 モラクセラ・カタラーリス（Ｍｏｒａｘｅｌｌａｃａｔａｒｒｈａｌｉｓ）のＢＡＳＢ１１４抗原およびその使用
EP00956338A EP1204678A1 (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof
PCT/EP2000/007293 WO2001009179A1 (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof
CN00811120A CN1367790A (zh) 1999-07-30 2000-07-27 粘膜炎莫拉氏菌basb114多肽抗原及其用途
HK02107831.6A HK1047943A1 (zh) 1999-07-30 2002-10-29 黏膜炎莫拉氏菌basb114抗原及其用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917977.2A GB9917977D0 (en) 1999-07-30 1999-07-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB9917977D0 true GB9917977D0 (en) 1999-09-29

Family

ID=10858278

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917977.2A Ceased GB9917977D0 (en) 1999-07-30 1999-07-30 Novel compounds

Country Status (8)

Country Link
EP (1) EP1204678A1 (ja)
JP (1) JP2003506027A (ja)
CN (1) CN1367790A (ja)
AU (1) AU6832200A (ja)
CA (1) CA2380295A1 (ja)
GB (1) GB9917977D0 (ja)
HK (1) HK1047943A1 (ja)
WO (1) WO2001009179A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154936B2 (en) * 2001-12-03 2006-12-26 Qualcomm, Incorporated Iterative detection and decoding for a MIMO-OFDM system
WO2004015099A2 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440425B1 (en) * 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella

Also Published As

Publication number Publication date
CN1367790A (zh) 2002-09-04
JP2003506027A (ja) 2003-02-18
CA2380295A1 (en) 2001-02-08
AU6832200A (en) 2001-02-19
HK1047943A1 (zh) 2003-03-14
WO2001009179A1 (en) 2001-02-08
EP1204678A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
GB9902084D0 (en) Novel compounds
GB9902697D0 (en) Novel compounds
GB9917977D0 (en) Novel compounds
GB9901256D0 (en) Novel compounds
GB9917975D0 (en) Novel compounds
GB9902937D0 (en) Novel compounds
GB9902880D0 (en) Novel compounds
GB9902070D0 (en) Novel compounds
GB9902168D0 (en) Novel compounds
GB9902086D0 (en) Novel compounds
GB9918033D0 (en) Novel compounds
GB9903536D0 (en) Novel compounds
GB9903535D0 (en) Novel compounds
GB9921692D0 (en) Novel compounds
GB9903417D0 (en) Novel compounds
GB9903416D0 (en) Novel compounds
GB9923156D0 (en) Novel compounds
GB9903414D0 (en) Novel compounds
GB9903402D0 (en) Novel compounds
GB9903278D0 (en) Novel compounds
GB9902936D0 (en) Novel compounds
GB9902879D0 (en) Novel compounds
GB9902657D0 (en) Novel compounds
GB9902169D0 (en) Novel compounds
GB9900952D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)